Tianjin Pharmaceutical Da Ren Tang Group

Results

Tianjin Pharmaceutical Da Ren Tang Group reports 3QFY2024 earnings of RMB146.1 mil, 8% higher y-o-y

The group's earnings fell by 6% y-o-y to RMB803.9 million for the 9MFY2024.
Raffles Medical leads; Tianjin Pharma, IHH Healthcare and Top Glove top own categories - THE EDGE SINGAPORE

Billion Dollar Club 2023

Raffles Medical leads; Tianjin Pharma, IHH Healthcare and Top Glove top own categories

Raffles Medical is expanding into new markets such as Vietnam
×